Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetProtachykinin-1
LigandBDBM50252513
Substrate/Competitorn/a
Ki 1000±n/a nM
CommentsPDSP_1600
Citation Schotte, AJanssen, PFGommeren, WLuyten, WHVan Gompel, PLesage, ASDe Loore, KLeysen, JE Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl)124:57-73 (1996) [PubMed]  Article
More Info.:Get all data from this article
 
Protachykinin-1
Name:Protachykinin-1
Synonyms:NKA | NKNA | Protachykinin-1 | Substance P | TAC1 | TAC2 | TKN1_HUMAN
Type:Enzyme Catalytic Domain
Mol. Mass.:15006.99
Organism:Homo sapiens (Human)
Description:Substance P 0 HUMAN::P20366
Residue:129
Sequence:
MKILVALAVFFLVSTQLFAEEIGANDDLNYWSDWYDSDQIKEELPEPFEHLLQRIARRPK
PQQFFGLMGKRDADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLMGKRALNSVAYERS
AMQNYERRR
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM50252513
n/a
NameBDBM50252513
Synonyms:3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one | 9-OH-risperidone | 9-hydroxy risperidone | CHEMBL1621 | Invega | PALIPERIDONE
TypeSmall organic molecule
Emp. Form.C23H27FN4O3
Mol. Mass.426.4839
SMILESCc1nc2C(O)CCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: